Long non-coding RNA Mir22hg-derived miR-22-3p promotes skeletal muscle differentiation and regeneration by inhibiting HDAC4

文献类型： 外文期刊

第一作者： Li, Rongyang

作者： Li, Rongyang;Cao, Yan;Li, Weijian;Dai, Weilong;Zhang, Liangliang;Zhang, Xuan;Ning, Caibo;Li, Hongqiang;Tao, Jingli;Jia, Chao;Wu, Wangjun;Liu, Honglin;Li, Bojiang;Yao, Yilong

作者机构：

期刊名称：MOLECULAR THERAPY-NUCLEIC ACIDS （ 影响因子：8.886； 五年影响因子：8.334 ）

ISSN： 2162-2531

年卷期： 2021 年 24 卷

页码：

收录情况： SCI

摘要： Emerging studies have indicated that long non-coding RNAs (lncRNAs) play important roles in skeletal muscle growth and development. Nevertheless, it remains challenging to understand the function and regulatory mechanisms of these lncRNAs in muscle biology and associated diseases. Here, we identify a novel lncRNA, Mir22hg, that is significantly upregulated during myoblast differentiation and is highly expressed in skeletal muscle. We validated that Mir22hg promotes myoblast differentiation in vitro. Mechanistically, Mir22hg gives rise to mature microRNA (miR)-22-3p, which inhibits its target gene, histone deacetylase 4 (HDAC4), thereby increasing the downstream myocyte enhancer factor 2C (MEF2C) and ultimately promoting myoblast differentiation. Furthermore, in vivo, we documented that Mir22hg knockdown delays repair and regeneration following skeletal muscle injury and further causes a significant decrease in weight following repair of an injured tibialis anterior muscle. Additionally, Mir22hg gives rise to miR-22-3p to restrict HDAC4 expression, thereby promoting the differentiation and regeneration of skeletal muscle. Given the conservation of Mir22hg between mice and humans, Mir22hg might constitute a promising new therapeutic target for skeletal muscle injury, skeletal muscle atrophy, as well as other skeletal muscle diseases.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序